ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹107 Cr | ₹96 Cr | ₹106 Cr | ₹78 Cr | ₹60 Cr |
What is the latest Total Current Liabilities ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹107 Cr |
| Mar2025 | ₹96 Cr |
| Mar2024 | ₹106 Cr |
| Mar2023 | ₹78 Cr |
| Mar2022 | ₹60 Cr |
How is Total Current Liabilities of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹107 Cr | 10.88 | |
| Mar2025 | ₹96 Cr | -9.51 | |
| Mar2024 | ₹106 Cr | 37.12 | |
| Mar2023 | ₹78 Cr | 28.37 | |
| Mar2022 | ₹60 Cr | - | |
Compare Total Current Liabilities of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹3,293.4 Cr | -1.1% | -2.3% | -12.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | -1.1% |
-2.3% |
-12.5% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses